ASCO GI 2023 Highlights Podcast Presented ByRobert van den Heuvel, Medicom ConferenceASCO GI 2023 6 February, 2023 23:36
Novel regimen may avoid TME surgery in rectal cancer ExpertDr Myriam Chalabi, Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands TrialPhase 1/2, TARZAN ConferenceASCO GI 2023 3 February, 2023 10:43
Palliative radiation therapy improves hepatic pain in HCC and liver metastasis ExpertDr Laura Dawson, Princess Margaret Cancer Centre, Canada ConferenceASCO GI 2023 3 February, 2023 10:37
New standard-of-care for colorectal cancer Presented ByProf. Josep Tabernero, Val d’Hebron University Hospital and Institute of Oncology, Spain TrialPhase 3, SUNLIGHT ConferenceASCO GI 2023 25 January, 2023 09:05
Novel Fc-enhanced CTLA-4 inhibitor scores in colorectal cancer Presented ByProf. Anthony El-Khoueiry, Norris Comprehensive Cancer Center, CA, USA TrialPhase 1, C-800 ConferenceASCO GI 2023 25 January, 2023 09:03
IMbrave 151 missed primary endpoint in advanced BTC Presented ByProf. Anthony El-Khoueiry, USC Norris Comprehensive Cancer Center, CA, USA TrialPhase 2, IMbrave151 ConferenceASCO GI 2023 25 January, 2023 09:02
Fucoidan may improve quality-of-life in patients with rectal cancer Presented ByProf. Jaw-Yuan Wang, Pingtung Hospital, Taiwan ConferenceASCO GI 2023 25 January, 2023 09:01
OPERA trial opts for non-surgical treatment for rectal cancer Presented ByProf. Arthur Sun Myint, Clatterbridge Cancer Centre, UK ConferenceASCO 2023 25 January, 2023 09:00
Zolbetuximab plus mFOLFOX6 scores in gastric cancer Presented ByDr Kohei Shitara, National Cancer Center Hospital East, Japan TrialPhase 3, SPOTLIGHT ConferenceASCO GI 2023 24 January, 2023 10:28
New first-line option for metastatic pancreatic duct cancer Presented ByProf. Zev Wainberg, University of California Los Angeles, CA, USA TrialPhase 3, NAPOLI-3 ConferenceASCO GI 2023 24 January, 2023 10:27
Nanvuranlat prolongs PFS in refractory advanced BTC Presented ByDr Junji Furuse , Kanagawa Cancer Center, Japan ConferenceASCO GI 2023 24 January, 2023 10:26
Sorafenib plus TACE may control HCC after resection Presented ByProf. Ming Kuang, The First Affiliated Hospital, China ConferenceASCO GI 2023 24 January, 2023 10:24
SWOG 1815, first-ever phase 3 trial in BTC, fails Presented ByProf. Rachna Shroff, University of Arizona Cancer Center, AZ, USA ConferenceASCO GI 2023 24 January, 2023 10:22
Novel treatment option for advanced gastric cancer Presented ByProf. Nick Pavlakis, University of Sydney, Australia TrialPhase 3, INTEGRATE IIa ConferenceASCO GI 2023 23 January, 2023 10:32
Radiotherapy relieves hepatic pain in HCC and liver metastasis Presented ByProf. Laura Dawson, Princess Margaret Cancer Centre, Canada ConferenceASCO GI 2023 23 January, 2023 10:30
Promising neoadjuvant therapy in gastric cancer Presented ByDr Filippo Pietrantonio, Fondazione IRCCS Istituto Nazionale dei Tumori, Italy TrialPhase 2, INFINITY ConferenceASCO GI 2023 23 January, 2023 10:28
Nivolumab plus chemotherapy continues to deliver in gastric cancer Presented ByDr Yelena Janjigian, Memorial Sloan Kettering Cancer, NY, USA TrialPhase 3, CheckMate 649 ConferenceASCO GI 2023 23 January, 2023 10:27
Excellent outcomes of LATG/LAPG in gastric cancer Presented ByDr Shinichi Sakuramoto, Saitama Medical University International Medical Center, Japan TrialJCOG1401 ConferenceASCO GI 2023 23 January, 2023 10:25